CPC
AIMT

Congress Park Capital’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Congress Park Capital’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5,500
Closed -$208K – 102
2017
Q4 		$208K Buy
+5,500
New +$208K 0.21% 92